Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

Carboplatin 129 pembrolizumab 124 Cisplatin 114 Paclitaxel 102 Gemcitabine 85 Specimen Handling 80 Magnetic Resonance Spectroscopy 80 Docetaxel 70 Dexamethasone 59 Cyclophosphamide 59 Pemetrexed 55 Bevacizumab 54 durvalumab 53 Doxorubicin 52 Radiotherapy 49 Capecitabine 49 Radiation 47 Oxaliplatin 47 Fluorouracil 47 Rituximab 42 Leucovorin 42 Vincristine 41 Lenalidomide 40 Etoposide 38 Letrozole 36 atezolizumab 35 Nivolumab 35 Prednisone 31 Bortezomib 31 130-nm albumin-bound paclitaxel 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × FOLFOXIRI protocol × 90 days × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡